In addition to our main findings, we were also able to demonstrate that patients stratified as high risk via the AASLD criteria presented with significantly higher ALT and AST levels, representing a more severe hepatitis, as well as a higher mean FIB‐4 score suggesting advanced hepatic fibrosis. This evidence concerns the gene GPT and Hepatitis.